Drug firm Ind-Swift Laboratories today reported an increase of 73.97 per cent in its net profit to Rs 21.7 crore for the second quarter ended September 30 2010.
The company's net profit for the same period last fiscal was Rs 12.4 crore, Ind-Swift Labs said in a filing to the Bombay Stock Exchange (BSE).
Total operating income of the company for the second quarter was Rs 212.8 crore as against Rs 196.4 crore for the same period previous fiscal.
For the six months ended September 30 this year the net profit of the company stood at Rs 36.6 crore, as against Rs 23.7 crore for the corresponding period last fiscal.
Total income of the company for the half year period this year stood at Rs 412.87 crore compared to Rs 366.78 crore in the same period last fiscal.
Shares of the company were trading at Rs 146.85 on BSE in late afternoon trade, up 0.69 per cent from its previous close.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app